Janux Therapeutics, Inc. Share Price
NASDAQ: JANX | Small CapJanux Therapeutics, Inc. Stock Performance
Janux Therapeutics, Inc. Share Price Today
As of 31 October 2026, Janux Therapeutics, Inc.'s share price is $17.49. The stock opened at $17.93, compared to its previous close of $17.82. During today's trading session, Janux Therapeutics, Inc.'s share price traded between $17.14 and $17.98, with an average price of $17.56. Over the past 52 weeks, the stock has recorded a high of $35.24 and a low of $12.14. In terms of performance, Janux Therapeutics, Inc.'s share price has risen by 21.80% over the last six months and is down 39.12% on a year-on-year basis.
Janux Therapeutics, Inc. Share Price Chart
Janux Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Janux Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Janux Therapeutics, Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
Janux Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $17.18 | $17.48 | +0.98% |
Sep 2026 | $18.23 | $17.32 | -7.73% |
Aug 2026 | $15.23 | $18.77 | +23.94% |
Jul 2026 | $15.36 | $15.14 | -1.30% |
Jun 2026 | $14.50 | $15.34 | +5.14% |
May 2026 | $14.20 | $14.59 | +1.60% |
Apr 2026 | $14.11 | $14.36 | +3.38% |
Mar 2026 | $13.40 | $13.89 | +1.91% |
Feb 2026 | $13.61 | $13.63 | -0.44% |
Jan 2026 | $13.75 | $13.69 | -0.80% |
Dec 2025 | $33.70 | $13.80 | -59.59% |
Nov 2025 | $28.32 | $34.15 | +18.87% |